What is the Lamin registry?
LAMIN is a North American registry that links North American and European sites through the PRIORITY network which is funded by the Leducq foundation. We are conducting a global genome-wide association study to determine the modifiers of disease presentation in patients with LMNA mutations.
- Determine the genetic modifiers that influence the different ways LMNA–
mediated disease may manifest - Understand the full phenotypic spectrum of LMNA variants
- Investigate the natural history of LMNA-mediated disease.
If you are a patient and interested in joining, we are approved for LMNA patients and families to self-enroll in our study if you desire. We may need to review your medical records to ensure that you are eligible for the study, but all medical records will be kept strictly confidential.
If you are a collaborator who is interested in joining or learning more about the registry, please click on the following link.
Duke University Children's Hospital
The LAMIN Registry is housed within the Duke University School of Medicine and part of Duke University Children’s Hospital. We are constantly striving to improve patient outcomes through research and clinical engagement.
Our Team
Andrew Landstrom, MD, PhD
Gabrielle Monaco
